S. H. Lim

453 total citations
9 papers, 133 citations indexed

About

S. H. Lim is a scholar working on Genetics, Oncology and Clinical Biochemistry. According to data from OpenAlex, S. H. Lim has authored 9 papers receiving a total of 133 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Oncology and 4 papers in Clinical Biochemistry. Recurrent topics in S. H. Lim's work include Bacterial Identification and Susceptibility Testing (4 papers), Neutropenia and Cancer Infections (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S. H. Lim is often cited by papers focused on Bacterial Identification and Susceptibility Testing (4 papers), Neutropenia and Cancer Infections (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). S. H. Lim collaborates with scholars based in United Kingdom and South Sudan. S. H. Lim's co-authors include Mark Smith, A. H. Goldstone, S. J. Machin, Robert Marcus, Trevor Baglin, G Hale, Herman Waldmann, Nina Salooja, J. Z. Wimperis and David J. Flavell and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, British Journal of Haematology and Blood Reviews.

In The Last Decade

S. H. Lim

9 papers receiving 122 citations

Peers

S. H. Lim
G.J. Timmers Netherlands
E Kaiserová Slovakia
R Cuvelier Belgium
Euri Seo South Korea
G.J. Timmers Netherlands
S. H. Lim
Citations per year, relative to S. H. Lim S. H. Lim (= 1×) peers G.J. Timmers

Countries citing papers authored by S. H. Lim

Since Specialization
Citations

This map shows the geographic impact of S. H. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. H. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. H. Lim more than expected).

Fields of papers citing papers by S. H. Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. H. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. H. Lim. The network helps show where S. H. Lim may publish in the future.

Co-authorship network of co-authors of S. H. Lim

This figure shows the co-authorship network connecting the top 25 collaborators of S. H. Lim. A scholar is included among the top collaborators of S. H. Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. H. Lim. S. H. Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lim, S. H., Mark Smith, S. J. Machin, & A. H. Goldstone. (1993). A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter‐related sepsis in patients receiving intensive chemotherapy for haematological malignancies. European Journal Of Haematology. 51(S54). 10–13. 35 indexed citations
2.
Lim, S. H., G Hale, Robert Marcus, Herman Waldmann, & Trevor Baglin. (1993). CAMPATH‐1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura. British Journal of Haematology. 84(3). 542–544. 47 indexed citations
3.
Lim, S. H., et al.. (1992). High‐dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease. European Journal Of Haematology. 48(2). 110–114. 4 indexed citations
4.
Lim, S. H. & Robert Marcus. (1992). Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas. Blood Reviews. 6(3). 157–162. 4 indexed citations
5.
Lim, S. H., Sheila J.M. O’Connor, David Bloxham, et al.. (1992). CD2+CD19+Biphenotypic Acute Lymphoblastic Leukaemia: A Report of Three Cases and a Review of the Literature. Leukemia & lymphoma. 6(2). 167–175. 2 indexed citations
6.
Lim, S. H., R. E. Marcus, & Trevor Baglin. (1991). A Pilot Study of Low Dose ARA-C, Interferon-Alpha and Cis-Retinoic Acid (AIR) Combination Therapy for Poor Risk Patients with Acute Myeloid Leukaemia. Leukemia & lymphoma. 5(5-6). 341–345. 1 indexed citations
7.
Lim, S. H., Mark Smith, Nina Salooja, S. J. Machin, & A. H. Goldstone. (1991). A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. Journal of Antimicrobial Chemotherapy. 28(1). 109–116. 20 indexed citations
8.
Lim, S. H., Mark Smith, S. J. Machin, & A. H. Goldstone. (1990). Prophylactic teicoplanin during insertion of Hickman catheters. British Journal of Haematology. 76(s2). 27–29. 7 indexed citations
9.
Lim, S. H., Mark Smith, A. H. Goldstone, & S. J. Machin. (1990). A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients. British Journal of Haematology. 76(s2). 41–44. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026